| Literature DB >> 29988277 |
Abstract
Experimental studies has been carried out to isolate and identify an active antifilarial compound from Vitex negundo L. plant as it has been used for treatment against filariasis in Indian traditional system of medicine. In vitro antifilarial assay has been carried out against adult filarial parasite Setaria cervi worms by both worm motility and MTT reduction assays. Levels of oxidative stress parameters MDA, carbonyl content and nitric oxide levels have been detected. The isolated compound exhibited significant antifilarial activity in dose dependent manner. The active compound has been chemically characterized and identified as 4,5-diethyl-3'-ethoxy-pyro-flavone.Entities:
Keywords: Antifilarial effect; Flavonoid; Setaria cervi; Vitex negundo L.
Year: 2018 PMID: 29988277 PMCID: PMC6011809 DOI: 10.1016/j.parepi.2018.03.002
Source DB: PubMed Journal: Parasite Epidemiol Control ISSN: 2405-6731
Fig. 3Dose-response curve of VN3 after 2 h motility inhibition.
In vitro antifilarial activity of compound against adult filarial parasite in term of MTT reduction assay.
| Sample | Incubation time (in h) | Test concentrations (in mg/ml) | Absorbance at 492 nm (mean ± S.E.M.) | % reduction relative to solvent controlC, heat killedH & treated wormsT | IC50 |
|---|---|---|---|---|---|
| CControl | 24 | – | 1.007 ± 0.03 | – | |
| HHeat killed | 0.5 | – | 0.325 ± 0.028 | – | |
| TCompound | 24 | 0.0005 | 0.905 ± 0.005 | 15 | |
| 20 | 0.001 | 0.816 ± 0.005 | 28.1 | ||
| 14 | 0.002 | 0.709 ± 0.006 | 43.7 | 0.0032 | |
| 10 | 0.005 | 0.570 ± 0.003 | 64.1 | ||
| 6 | 0.01 | 0.463 ± 0.008 | 79.8 | ||
| 2 | 0.02 | 0.329 ± 0.144 | 99.5 |
CPositive control, Hnegative control, Ttreated worm with compound.
P value represents the level of significance P < 0.05 when comparing the mean value of absorbance observed for the formazan formed between treated and control worms.
Fig. 1FT-IR chromatogram of the isolated compound VN3.
Fig. 2(a) 1H NMR and (b) 13C NMR analysis of the isolated compound in CDCl3.
Fig. 5Chemical structure of VN3 [4,5-diethyl-3′-ethoxy-pyro-flavone].
Levels of MDA, carbonyl content and nitric oxide levels in culture supernatants (nM/ml) of compound: results shown are mean ± S.E.M.
| Concentration of compound (mg/ml) | MDA levels (nM/ml) | Carbonyl content (nM/mg) | Nitric oxide levels (μM/ml) |
|---|---|---|---|
| Control | 0.3 ± 0.057 | 0.02 ± 0.008 | 0.004 ± 0.001 |
| 0.0005 | 0.5 ± 0.057 | 0.06 ± 0.05 | 0.007 ± 0.01 |
| 0.001 | 0.9 ± 0.009 | 0.12 ± 0.02 | 0.011 ± 0.06 |
| 0.002 | 1.6 ± 0.152 | 0.29 ± 0.009 | 0.023 ± 0.001 |
| 0.005 | 1.8 ± 0.057 | 0.54 ± 0.009 | 0.049 ± 0.01 |
| 0.01 | 2.3 ± 0.152 | 0.73 ± 0.025 | 0.076 ± 0.001 |
| 0.02 | 3.5 ± 0.152 | 0.96 ± 0.011 | 0.095 ± 0.001 |
Significant at the level of P < 0.05 when compared with respective control level.
Fig. 4Levels of (a) MDA, (b) carbonyl content and (c) nitric oxide after 24 h incubation in the in vitro experiments for the effect of the compound on parasite motility.